For instance, treatment with TCP or TCP analogues in breast cancer cell lines inhibited proliferation, but at concentrations 20–30 fold higher than the half maximal inhibitory concentration (IC50) of LSD1. The gene discussed is KDM1A; the disease is breast carcinoma.